Abou-Samra M, Dubuisson N, Marino A, Selvais C, Romain V, Davis-Lopez de Carrizosa M
Antioxidants (Basel). 2025; 13(12.
PMID: 39765879
PMC: 11674016.
DOI: 10.3390/antiox13121551.
Schreiber J, Rotard L, Tourneur Y, Lafoux A, Berthier C, Allard B
J Gen Physiol. 2024; 157(2).
PMID: 39718509
PMC: 11668172.
DOI: 10.1085/jgp.202413588.
Starnes J, Weiner J, George-Durrett K, Crum K, Henderson C, Campbell M
Circ Cardiovasc Imaging. 2024; 17(12):e017287.
PMID: 39629588
PMC: 11652209.
DOI: 10.1161/CIRCIMAGING.124.017287.
Lee A, Kwon H, Kim S, Jeong Y, Choi B, Kho C
Korean J Physiol Pharmacol. 2024; 29(2):235-244.
PMID: 39539181
PMC: 11842294.
DOI: 10.4196/kjpp.24.246.
Milan M, Maiullari F, Chirivi M, Ceraolo M, Zigiotto R, Soluri A
J Pathol. 2024; 265(1):1-13.
PMID: 39523812
PMC: 11638662.
DOI: 10.1002/path.6362.
Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model.
Hasegawa J, Nagata T, Ihara K, Tanihata J, Ebihara S, Yoshida-Tanaka K
Nat Commun. 2024; 15(1):7530.
PMID: 39327422
PMC: 11427662.
DOI: 10.1038/s41467-024-48204-5.
Functional cardiac consequences of β-adrenergic stress-induced injury in a model of Duchenne muscular dystrophy.
Earl C, Javier A, Richards A, Markham L, Goergen C, Welc S
Dis Model Mech. 2024; 17(10).
PMID: 39268580
PMC: 11488649.
DOI: 10.1242/dmm.050852.
A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in Mice.
Gasparella F, Nogara L, Germinario E, Tibaudo L, Ciciliot S, Piccoli G
Antioxidants (Basel). 2024; 13(6).
PMID: 38929061
PMC: 11201281.
DOI: 10.3390/antiox13060622.
Cyclo His-Pro Attenuates Muscle Degeneration in Murine Myopathy Models.
De Masi A, Zanou N, Strotjohann K, Lee D, Lima T, Li X
Adv Sci (Weinh). 2024; 11(28):e2305927.
PMID: 38728626
PMC: 11267275.
DOI: 10.1002/advs.202305927.
Functional cardiac consequences of β-adrenergic stress-induced injury in the mouse model of Duchenne muscular dystrophy.
Earl C, Javier A, Richards A, Markham L, Goergen C, Welc S
bioRxiv. 2024; .
PMID: 38659739
PMC: 11042272.
DOI: 10.1101/2024.04.15.589650.
Why is early-onset atrial fibrillation uncommon in patients with Duchenne muscular dystrophy? Insights from the mdx mouse.
Nguyen M, Hooper C, Stefanini M, Vrellaku B, Carnicer R, Wood M
Cardiovasc Res. 2024; 120(5):519-530.
PMID: 38270932
PMC: 11060487.
DOI: 10.1093/cvr/cvae022.
Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy.
Loboda A, Dulak J
Cells. 2024; 13(2).
PMID: 38247849
PMC: 10814317.
DOI: 10.3390/cells13020158.
Considering impact of age and sex on cardiac cytoskeletal components.
Jones T, Woulfe K
Am J Physiol Heart Circ Physiol. 2023; 326(3):H470-H478.
PMID: 38133622
PMC: 11219061.
DOI: 10.1152/ajpheart.00619.2023.
Mechanisms of reduced myocardial energetics of the dystrophic heart.
Stevens J, Dobratz T, Fischer K, Palmer A, Bourdage K, Wong A
Am J Physiol Heart Circ Physiol. 2023; 326(2):H396-H407.
PMID: 38099842
PMC: 11219055.
DOI: 10.1152/ajpheart.00636.2023.
Receptor interacting protein kinase-3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy.
Bencze M, Periou B, Punzon I, Barthelemy I, Taglietti V, Hou C
J Cachexia Sarcopenia Muscle. 2023; 14(6):2520-2531.
PMID: 37909859
PMC: 10751447.
DOI: 10.1002/jcsm.13265.
Dystrophic cardiomyopathy: role of the cardiac myofilaments.
George T, Hanft L, Krenz M, Domeier T, McDonald K
Front Physiol. 2023; 14:1207658.
PMID: 37362434
PMC: 10288979.
DOI: 10.3389/fphys.2023.1207658.
RANKL Inhibition Reduces Cardiac Hypertrophy in Mice and Possibly in Children with Duchenne Muscular Dystrophy.
Marcadet L, Juracic E, Khan N, Bouredji Z, Yagita H, Ward L
Cells. 2023; 12(11).
PMID: 37296659
PMC: 10253225.
DOI: 10.3390/cells12111538.
Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.
Eisen B, Binah O
Int J Mol Sci. 2023; 24(10).
PMID: 37240001
PMC: 10218670.
DOI: 10.3390/ijms24108657.
Oligonucleotide Enhancing Compound Increases Tricyclo-DNA Mediated Exon-Skipping Efficacy in the Mdx Mouse Model.
Bizot F, Fayssoil A, Gastaldi C, Irawan T, Phongsavanh X, Mansart A
Cells. 2023; 12(5).
PMID: 36899837
PMC: 10001065.
DOI: 10.3390/cells12050702.
Two-dimensional speckle tracking echocardiography demonstrates improved myocardial function after intravenous infusion of bone marrow mesenchymal stem in the X-Linked muscular dystrophy mice.
Liu X, Yao S, Pan M, Cai Y, Shentu W, Cai W
BMC Cardiovasc Disord. 2022; 22(1):461.
PMID: 36329408
PMC: 9635191.
DOI: 10.1186/s12872-022-02886-1.